VP, Franchise Portfolio Management

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients. For more information, visit www.azurity.com.

Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization.

Job Description summary

The VP of Franchise Portfolio Management, as a leader within Azurity’s Strategic Portfolio Management function, plans, builds and manages a balanced product portfolio through the entire lifecycle (“cradle to grave”) to meet assigned category targets within Azurity’s 5-yr financial model. They ideate, select and oversee development of a portfolio of assets within the category that fit Azurity criteria, match patient needs and market opportunity with internal technical capabilities to develop products. They also inform BD efforts to supplement what can be developed internally. They employ a wide range of techniques to determine customer needs and analyze multiple data sources to determine strategy for the category.   They own the PLM process from the point of ideation through to the end of life of the product, leading cross-functional teams to drive the process for development and launch, subsequent product enhancements or line-extensions and, eventually, the decision to cease commercial efforts.

KEY RESPONSIBILITIES

• Maintain a comprehensive subject matter expertise for the category through primary and secondary research, ad boards, market scanning, competitive intelligence and customer input.
• Ideate and select products to construct a funnel of candidates for development, each with a compelling and distinct TPP, subsequently driving progress through development, registration and launch.
• Continue to drive product enhancements and line-extensions beyond launch and plan effectively for replacement and withdrawal of commercial support at end of life.
• Own and drive PLM process stage-gates 1-9 at scale and speed (“cradle to grave”), convening and leading A3 Cross-functional teams. Ensure stage-gate criteria are met at every stage. “Push” each function to deliver effectively and to budget at each stage from development, through launch, growth and maturity. Recommend discontinuations as appropriate.
• Develop and maintain a balanced strategic plan for the category (stage, dose-form, technology etc.), managing replacement of mature assets and growing category revenues over the long-term
• Challenge business development to provide assets that supplement the internally developed portfolio
• Develop external partnerships to access new technologies and otherwise enhance portfolio development

IDEAL EXPERIENCE AND SKILLS

1. Entrepreneurial mindset and drive
2. Cross-functional leadership and ability to drive action through others
3. Business acumen
4. Category therapeutic knowledge
5. Familiarity with pharmaceutical drug development, commercial processes and product lifecycles. Understanding of regulatory processes and IP evaluation
6. Strong criteria-based decision-making and execution capabilities.
7. Product selection expertise, creation of TPPs and life-cycle management
8. Curiosity/industry network
9. Financial modeling, forecasting and P&L construction
10. Ability to take a systematic approach, driving forward a large number of projects simultaneously through stage-gate go/no-go decisions
11. Batchelor’s Degree
12. Pharmaceuticals, Inc.

CRITICAL LEADERSHIP CAPABILITIES

1. Ownership of the category success. Will to drive progress.
2. Sense of urgency and ability to instil that in oth